Synergy Pharmaceuticals Initiates Phase 3 Clinical Trial of Plecanatide in Patients with Chronic Idiopathic Constipation

Synergy Pharmaceuticals (NASDAQ: SGYP ) today announced the start of the first of two planned phase 3 clinical trials to confirm the safety and efficacy of plecanatide, its lead GC-C agonist and